Alper Özseven1, Bahar Dirican2. 1. Suleyman Demirel University, Medical Faculty, Isparta, Turkey. 2. University of Health Sciences, Gulhane Medical Faculty, Ankara, Turkey.
Abstract
BACKGROUND: Currently, CBCT system is an indispensable component of radiation therapy units. Because of that, it is important in treatment planning and diagnosis. CBCT is also an crucial tool for patient positioning and verification in image-guided radiation therapy (IGRT). Therefore, it is critical to investigate the patient organ doses arising from CBCT imaging. The purpose of this study is to evaluate patient organ doses and effective dose to patients from three different protocols of Elekta Synergy XVI system for kV CBCT imaging examinations in image guided radiation therapy. MATERIALS AND METHODS: Organ dose measurements were done with thermoluminescent dosimeters in Alderson RA NDO male phantom for head & neck (H&N), chest and pelvis protocols of the Elekta Synergy XVI kV CBCT system. From the measured organ dose, effective dose to patients were calculated according to the International Commission on Radiological Protection 103 report recommendations. RESULTS: For H&N, chest and pelvis scans, the organ doses were in the range of 0.03-3.43 mGy, 6.04-22.94 mGy and 2.5-25.28 mGy, respectively. The calculated effective doses were 0.25 mSv, 5.56 mSv and 4.72 mSv, respectively. CONCLUSION: The obtained results were consistent with the most published studies in the literature. Although the doses to patient organs from the kV CBCT system were relatively low when compared with the prescribed treatment dose, the amount of delivered dose should be monitored and recorded carefully in order to avoid secondary cancer risk, especially in pediatric examinations.
BACKGROUND: Currently, CBCT system is an indispensable component of radiation therapy units. Because of that, it is important in treatment planning and diagnosis. CBCT is also an crucial tool for patient positioning and verification in image-guided radiation therapy (IGRT). Therefore, it is critical to investigate the patient organ doses arising from CBCT imaging. The purpose of this study is to evaluate patient organ doses and effective dose to patients from three different protocols of Elekta Synergy XVI system for kV CBCT imaging examinations in image guided radiation therapy. MATERIALS AND METHODS: Organ dose measurements were done with thermoluminescent dosimeters in Alderson RA NDO male phantom for head & neck (H&N), chest and pelvis protocols of the Elekta Synergy XVI kV CBCT system. From the measured organ dose, effective dose to patients were calculated according to the International Commission on Radiological Protection 103 report recommendations. RESULTS: For H&N, chest and pelvis scans, the organ doses were in the range of 0.03-3.43 mGy, 6.04-22.94 mGy and 2.5-25.28 mGy, respectively. The calculated effective doses were 0.25 mSv, 5.56 mSv and 4.72 mSv, respectively. CONCLUSION: The obtained results were consistent with the most published studies in the literature. Although the doses to patient organs from the kV CBCT system were relatively low when compared with the prescribed treatment dose, the amount of delivered dose should be monitored and recorded carefully in order to avoid secondary cancer risk, especially in pediatric examinations.
Authors: Marina Ernst; Peter Manser; Karl Dula; Werner Volken; Marco Fm Stampanoni; Michael K Fix Journal: Dentomaxillofac Radiol Date: 2017-07-27 Impact factor: 2.419
Authors: Mireille Conrad; Grégory Bolard; Marie Nowak; Berardino De Bari; Wendy Jeanneret-Sozzi; Jean Bourhis; Jean-François Germond; François Bochud; Raphaël Moeckli Journal: Z Med Phys Date: 2018-02-06 Impact factor: 4.820
Authors: Clayton B Hess; Holly M Thompson; Stanley H Benedict; J Anthony Seibert; Kenneth Wong; Andrew T Vaughan; Allen M Chen Journal: Int J Radiat Oncol Biol Phys Date: 2016-01-05 Impact factor: 7.038
Authors: Daniel E Hyer; Christopher F Serago; Siyong Kim; Jonathan G Li; David E Hintenlang Journal: J Appl Clin Med Phys Date: 2010-04-17 Impact factor: 2.102